more

Mesa Laboratories (MLAB)

(Delayed Data from NSDQ)

$102.44 USD

-2.17 (-2.07%)

Updated Nov 15, 2024 03:59 PM ET

After-Market: $102.39 -0.05 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.10%
2	Buy	17.80%
3	Hold	9.50%
4	Sell	2.70%
5	Strong Sell	2.70%
S&P	500	11.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth B Momentum A VGM

Industry Rank:

Top 24% (59 out of 250)

Industry: Medical - Instruments

View All Zacks #1 Ranked Stocks

Zacks News

Neogen Introduces Test for Listeria in Environmental Samples

by Zacks Equity Research Published on July 11,2017

Neogen Corporation (NEOG) recently developed Listeria Right Now test system.

FDA Approval Widens Medtronic's (MDT) TAVR Platform Reach

by Zacks Equity Research Published on July 11,2017

Medtronic plc (MDT), a well established player in the medical technology, services and solutions space, recently announced FDA approval for the extended use of its self-expanding CoreValve Evolut transcatheter aortic valve replacement (TAVR) platform.

Myriad Genetics to Grow with Study Successes, New Alliances

by Zacks Equity Research Published on July 10,2017

On Jul 6, we issued an updated research report on Myriad Genetics, Inc. (MYGN).

Investors Look for Gains as Abbott Labs Set to Acquire Alere

by Zacks Equity Research Published on July 10,2017

On majority of Alere shareholders' recent approval in favor of the merger with Abbott (ABT), the deal is now expected to close by the end of third-quarter 2017.

Becton, Dickinson (BDX) Poised on C.R. Bard Acquisition

by Zacks Equity Research Published on July 10,2017

On Jul 7, we issued an updated research report on Franklin Lakes, NJ-based Becton, Dickinson and Company (BDX).

ResMed Sees Potential in SDB Market, Eyes Global Growth

by Zacks Equity Research Published on July 07,2017

On Jul 6, we issued an updated research report on San Diego, CA-based ResMed, Inc. (RMD).

Baxter and TAU Ink New Licensing Agreements through Ramot

by Zacks Equity Research Published on July 07,2017

Baxter International (BAX) has recently teamed up with Tel Aviv University, Israel's largest research and teaching university (TAU), on two new licensing agreements through Ramot.

Mazor Expects Higher Q2 Revenues, Wins Mazor X Orders

by Zacks Equity Research Published on July 07,2017

Mazor Robotics Ltd. (MZOR), recently announced that it expects to report second-quarter 2017 revenue of approximately $15.4 million compared with $8.3 million from the year-ago quarter.

Edwards Lifesciences' INSPIRIS RESILIA Valve Wins FDA Nod

by Zacks Equity Research Published on July 06,2017

Edwards Lifesciences Corporation (EW) recently announced the receipt of FDA approval for its INSPIRIS RESILIA aortic valve.

Will Walgreens Gain from Revised Rite Aid Agreement?

by Zacks Equity Research Published on July 06,2017

The new agreement would enable Walgreens Boots Alliance (WBA) to buy nearly half of the Rite Aid business at a deal value, almost one-third of the original price.

Envision Healthcare Rallies on Infinity Healthcare Buyout

by Zacks Equity Research Published on July 06,2017

Envision Healthcare Corporation (EVHC) recently announced that Envision Physician Services has acquired Infinity Healthcare, a multi-specialty physician group practice.

Exactech (EXAC) Launches Application for Knee Replacement

by Zacks Equity Research Published on July 06,2017

Gainesville, FL-based Exactech Inc. (EXAC) recently announced the launch of a new software application christened ExactechGPS TKA PLUS.

Civitas Solutions (CIVI) Acquires Country Life Care Center

by Zacks Equity Research Published on July 06,2017

Civitas Solutions, Inc. (CIVI) recently announced the acquisition of Country Life Care Center, a rehabilitation and post-acute care facility located in Riverton, UT.